Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. [PDF]
Kenneth G. Mann
openalex +1 more source
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis
ABSTRACT Objectives To investigate the value of cytokine, chemokine, and neurofilament light chain (NfL) concentrations in predicting relapse risk, chronic epilepsy, and functional impairment in LGI1 autoimmune encephalitis (AE). Methods Cytokines/chemokines (IL‐1‐beta, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8/CXCL8, IL‐10, IL‐12p70, IL‐13, IL‐17A, GM‐CSF, TNF ...
Albert Aboseif+17 more
wiley +1 more source
Perinatal ischemic stroke in an infant with factor VII deficiency: A CARE-compliant case report. [PDF]
Chou IL+5 more
europepmc +1 more source
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study. [PDF]
Halimeh S+6 more
europepmc +1 more source
Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.
Robert Radcliffe, Yale Nemerson
openalex +1 more source
Binding of Antibodies onto the Thylakoid Membrane VII. Localization of Coupling Factor of Photophosphorylation in the Lamellar System of Chloroplasts from Antirrhinum majus [PDF]
Alfons Radunz, Renate Meier
openalex +1 more source
ICU‐EEG Pattern Detection by a Convolutional Neural Network
ABSTRACT Objective Patients in the intensive care unit (ICU) often require continuous EEG (cEEG) monitoring due to the high risk of seizures and rhythmic and periodic patterns (RPPs). However, interpreting cEEG in real time is resource‐intensive and heavily relies on specialized expertise, which is not always available.
Giulio Degano+5 more
wiley +1 more source
A Family With Factor VII Deficiency: A Possible Autosomal Dominant Transmission. [PDF]
Song Z, Garcia S, Nandhagopal T, Kim S.
europepmc +1 more source
In vivo studies of the role of factor VII in hemostasis [PDF]
AR Giles+3 more
openalex +1 more source
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald+74 more
wiley +1 more source